|
Creative Medical Technology Holdings, Inc. (CELZ) Valoración de DCF
US | Healthcare | Biotechnology | NASDAQ
|
- ✓ Completamente Editable: Adáptelo A Sus Necesidades En Excel O Sheets
- ✓ Diseño Profesional: Plantillas Confiables Y Estándares De La Industria
- ✓ Predeterminadas Para Un Uso Rápido Y Eficiente
- ✓ No Se Necesita Experiencia; Fáciles De Seguir
Creative Medical Technology Holdings, Inc. (CELZ) Bundle
¡Agilice su análisis y mejore la precisión con nuestra calculadora DCF (CELZ)! Utilizando datos reales de Creative Medical Technology Holdings, Inc. y suposiciones personalizables, esta herramienta le permite pronosticar, analizar y valor (CELZ) al igual que un inversor experimentado.
Discounted Cash Flow (DCF) - (USD MM)
| Year | AY1 2019 |
AY2 2020 |
AY3 2021 |
AY4 2022 |
AY5 2023 |
FY1 2024 |
FY2 2025 |
FY3 2026 |
FY4 2027 |
FY5 2028 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | .2 | .2 | .1 | .1 | .0 | .0 | .0 | .0 | .0 | .0 |
| Revenue Growth, % | 0 | -0.60423 | -46.65 | 0.96406 | -89.84 | -34.03 | -34.03 | -34.03 | -34.03 | -34.03 |
| EBITDA | -1.1 | -1.0 | -3.0 | -10.2 | -5.5 | .0 | .0 | .0 | .0 | .0 |
| EBITDA, % | -666.6 | -637.11 | -3457.24 | -11458.56 | -61394.98 | -100 | -100 | -100 | -100 | -100 |
| Depreciation | .0 | .1 | .1 | .1 | .1 | .0 | .0 | .0 | .0 | .0 |
| Depreciation, % | 16.28 | 40.6 | 104.93 | 103.93 | 1050.93 | 71.38 | 71.38 | 71.38 | 71.38 | 71.38 |
| EBIT | -1.1 | -1.1 | -3.1 | -10.2 | -5.6 | .0 | .0 | .0 | .0 | .0 |
| EBIT, % | -682.88 | -677.71 | -3562.17 | -11562.5 | -62445.91 | -100 | -100 | -100 | -100 | -100 |
| Total Cash | .1 | .1 | 10.7 | 18.4 | 10.0 | .0 | .0 | .0 | .0 | .0 |
| Total Cash, percent | .0 | .0 | .0 | .0 | .1 | .0 | .0 | .0 | .0 | .0 |
| Account Receivables | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Account Receivables, % | 3.38 | 0 | 2.83 | 0 | 0 | 1.24 | 1.24 | 1.24 | 1.24 | 1.24 |
| Inventories | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Inventories, % | 0 | 0 | 12.38 | 11.51 | 73.27 | 19.43 | 19.43 | 19.43 | 19.43 | 19.43 |
| Accounts Payable | .3 | .4 | .8 | 3.3 | .3 | .0 | .0 | .0 | .0 | .0 |
| Accounts Payable, % | 193.83 | 213.31 | 868.18 | 3687.97 | 3525.33 | 100 | 100 | 100 | 100 | 100 |
| Capital Expenditure | .0 | -.3 | .0 | .0 | -.1 | .0 | .0 | .0 | .0 | .0 |
| Capital Expenditure, % | 0 | -151.98 | 0 | 0 | -1111.11 | -40 | -40 | -40 | -40 | -40 |
| Tax Rate, % | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EBITAT | -1.4 | -1.2 | -2.4 | -10.1 | -5.6 | .0 | .0 | .0 | .0 | .0 |
| Depreciation | ||||||||||
| Changes in Account Receivables | ||||||||||
| Changes in Inventories | ||||||||||
| Changes in Accounts Payable | ||||||||||
| Capital Expenditure | ||||||||||
| UFCF | -1.0 | -1.3 | -1.9 | -7.5 | -8.6 | -.3 | .0 | .0 | .0 | .0 |
| WACC, % | 28.08 | 28.08 | 28.08 | 28.08 | 28.08 | 28.08 | 28.08 | 28.08 | 28.08 | 28.08 |
| PV UFCF | ||||||||||
| SUM PV UFCF | -.2 | |||||||||
| Long Term Growth Rate, % | 2.00 | |||||||||
| Free cash flow (T + 1) | 0 | |||||||||
| Terminal Value | 0 | |||||||||
| Present Terminal Value | 0 | |||||||||
| Enterprise Value | 0 | |||||||||
| Net Debt | -3 | |||||||||
| Equity Value | 3 | |||||||||
| Diluted Shares Outstanding, MM | 1 | |||||||||
| Equity Value Per Share | 2.29 |
What You Will Get
- Pre-Filled Financial Model: Creative Medical Technology Holdings, Inc.'s (CELZ) actual data allows for accurate DCF valuation.
- Full Forecast Control: Modify revenue growth, profit margins, WACC, and other essential parameters.
- Instant Calculations: Automatic updates provide real-time results as you adjust inputs.
- Investor-Ready Template: A polished Excel file crafted for high-quality valuation presentations.
- Customizable and Reusable: Designed for adaptability, enabling repeated use for comprehensive forecasts.
Key Features
- Comprehensive Data: Access Creative Medical Technology Holdings, Inc.’s (CELZ) historical financial reports and projected forecasts.
- Customizable Parameters: Modify WACC, tax rates, revenue growth, and EBITDA margins to fit your analysis.
- Real-Time Insights: Watch the intrinsic value of Creative Medical Technology Holdings, Inc. (CELZ) update instantly.
- Intuitive Visualizations: Dashboard graphs illustrate valuation outcomes and essential metrics clearly.
- Designed for Precision: A reliable tool tailored for analysts, investors, and finance professionals.
How It Works
- Step 1: Download the Excel file for Creative Medical Technology Holdings, Inc. (CELZ).
- Step 2: Examine the pre-filled financial data and projections for CELZ.
- Step 3: Adjust key inputs such as revenue growth, WACC, and tax rates (highlighted cells).
- Step 4: Observe the DCF model refresh in real-time as you modify your assumptions.
- Step 5: Evaluate the outputs and leverage the results for your investment strategies.
Why Choose This Calculator for Creative Medical Technology Holdings, Inc. (CELZ)?
- User-Friendly Interface: Perfectly crafted for both novices and seasoned users.
- Customizable Inputs: Adjust parameters effortlessly to suit your analysis needs.
- Real-Time Feedback: Observe immediate updates to CELZ’s valuation as you modify inputs.
- Pre-Loaded Data: Comes equipped with Creative Medical’s latest financial information for swift evaluations.
- Relied Upon by Experts: Favored by investors and analysts for making well-informed choices.
Who Should Use This Product?
- Investors: Accurately evaluate Creative Medical Technology Holdings, Inc.'s (CELZ) fair value prior to making investment choices.
- CFOs: Utilize a professional-grade DCF model for financial analysis and reporting related to (CELZ).
- Consultants: Efficiently customize the template for valuation reports tailored to clients interested in (CELZ).
- Entrepreneurs: Acquire knowledge on financial modeling strategies employed by leading companies, including (CELZ).
- Educators: Implement it as a teaching resource to illustrate valuation techniques applicable to (CELZ).
What the Template Contains
- Historical Data: Includes Creative Medical Technology Holdings, Inc.'s (CELZ) past financials and baseline forecasts.
- DCF and Levered DCF Models: Detailed templates to calculate Creative Medical Technology Holdings, Inc.'s (CELZ) intrinsic value.
- WACC Sheet: Pre-built calculations for Weighted Average Cost of Capital specific to Creative Medical Technology Holdings, Inc. (CELZ).
- Editable Inputs: Modify key drivers like growth rates, EBITDA %, and CAPEX assumptions relevant to Creative Medical Technology Holdings, Inc. (CELZ).
- Quarterly and Annual Statements: A complete breakdown of Creative Medical Technology Holdings, Inc.'s (CELZ) financials.
- Interactive Dashboard: Visualize valuation results and projections for Creative Medical Technology Holdings, Inc. (CELZ) dynamically.